|Bid||77.76 x 1200|
|Ask||86.88 x 900|
|Day's range||79.21 - 81.01|
|52-week range||76.77 - 105.99|
|Beta (5Y monthly)||1.42|
|PE ratio (TTM)||16.81|
|Earnings date||02 Aug 2022 - 08 Aug 2022|
|Forward dividend & yield||2.06 (2.56%)|
|Ex-dividend date||12 May 2022|
|1y target est||105.91|
The acquisition of Fluxa will enable Emerson (EMR) to offer customers a comprehensive line of solutions for developing new drugs.
ST. LOUIS, June 30, 2022--Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines. The acquisition builds on Emerson’s leading software and solutions portfolio and life sciences expertise. Emerson made an equity investment in Fluxa, which is based in Glendale, California, in 2021.
RÉUNION ISLAND, June 28, 2022--Global technology and software company Emerson (NYSE: EMR) has been selected by Albioma (PAR: ABIO), a French independent energy provider, to help transition its coal-fired Bois Rouge plant to 100% renewable energy. As part of Albioma’s wider mission to transition all of its existing fossil fuel plants to renewable energy, Emerson’s automation systems and software will enable the coal-fired power station to convert to biomass feedstock.